Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Idiopathic Pulmonary Fibrosis, Healthy. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Determination of Functional Exercise Capacity, Peripheral Muscle Strength, Respiratory Muscle Endurance and Parameters Affecting Quality of Life in Idiopathic Pulmonary Fibrosis
Overview
There are not enough studies in the literature comparing functional capacity, respiratory functions and muscle strength of IPF patients with healthy individuals. This study aims to compare functional capacity, respiratory functions and muscle strength of IPF patients with healthy individuals.
Primary outcome measures
- 6 Minute Walk Test (6MWT) [Time frame: 1 month]
- 6 Minute Pegboard and Ring Test [Time frame: 1 month]
- 30-second sit to stand test [Time frame: 1 month]
- Forced Vital Capasity [Time frame: 1 month]
- Respiratory Muscle Strength Assessment [Time frame: 1 month]
- Respiratory Muscle Endurance Test [Time frame: 1 month]
- Hand Grip Strength [Time frame: 1 month]
- Quadriceps Strength [Time frame: 1 month]
- Respiratory Function Testing [Time frame: 1 month]
- Forced expiratory volume in 1 second [Time frame: 1 month]
Secondary outcome measures (4)
- TAMPA KINESOPHOBIA SCALE [Time frame: 1 month]
- LEICESTER COUGH QUESTIONNAIRE [Time frame: 1 month]
- St. George's Respiratory Questionnaire (SQRQ) [Time frame: 1 month]
- Bouchard Three-Day Physical Activity Record [Time frame: 1 month]
Eligibility criteria
Inclusion criteria
- Being over 18 years old
- having a clinical, radiological and/or pathological diagnosis of IPF
- volunteering to participate in the study
- not having had a respiratory tract infection in the last month
- not having an accompanying airway disease such as COPD
- being in the stable phase of the disease
Exclusion criteria
- Patients who have had an IPF attack within the last three months and/or are in the acute exacerbation of the disease; who use a walking aid; who have unstable angina or class III-IV heart failure according to the New York Heart Association congestive heart failure classification; who have orthopedic, neuromuscular, neurological and cardiac diseases that may affect walking and balance; who have serious comorbid conditions such as cancer or neoplasm; who have a history of sarcoidosis, tuberculosis, emphysema and/or lung surgery; who have communication problems, mental and cognitive problems, and who cannot adapt to the applied assessment methods will be excluded from the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-control
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06668051 · GO 23/14